Sarepta Therapeutics (SRPT) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39% |
| Dec 31, 2025 | 9.12% |
| Sep 30, 2025 | -9.43% |
| Jun 30, 2025 | 6.02% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | 26.12% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | 20.64% |
| Mar 31, 2024 | 22.93% |
| Dec 31, 2023 | 29.03% |
| Sep 30, 2023 | 33.13% |
| Jun 30, 2023 | 25.38% |
| Mar 31, 2023 | 31.41% |
| Dec 31, 2022 | 46.97% |
| Sep 30, 2022 | 48.75% |
| Jun 30, 2022 | 110.32% |
| Mar 31, 2022 | 38.58% |
| Dec 31, 2021 | 34.09% |
| Sep 30, 2021 | 22.77% |
| Jun 30, 2021 | 33.54% |
| Mar 31, 2021 | 33.62% |
| Dec 31, 2020 | 35.99% |
| Sep 30, 2020 | 36.47% |
| Jun 30, 2020 | 36.03% |
| Mar 31, 2020 | 11.16% |
| Dec 31, 2019 | 30.83% |
| Sep 30, 2019 | 34.68% |
| Jun 30, 2019 | 28.75% |
| Mar 31, 2019 | 29.97% |
| Dec 31, 2018 | 28.54% |
| Sep 30, 2018 | 26.95% |
| Jun 30, 2018 | 45.85% |
| Mar 31, 2018 | 44.50% |
| Dec 31, 2017 | 42.86% |
| Sep 30, 2017 | 58.50% |
| Jun 30, 2017 | 41.55% |
| Mar 31, 2017 | 51.83% |
| Dec 31, 2016 | 59.04% |
| Sep 30, 2016 | 74.48% |
| Jun 30, 2016 | 56.96% |
| Mar 31, 2016 | 42.34% |
| Dec 31, 2015 | 58.78% |
| Sep 30, 2015 | 62.02% |